Table 2 ADAMTS13 activity levels and anti-ADAMTS13 antibodies during pregnancy of women included in the study
From: Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case–control study
Patient | ADAMTS13 activity, by FRET | Anti-ADAMTS13 IgG, by WB (%, by ELISA) | ||||
|---|---|---|---|---|---|---|
1 T | 2 T | 3 T | 1 T | 2 T | 3 T | |
1 | <3 | <3 | on PEX | P (4) | P (5) | on PEX |
2 | <3 | on PEX | P (3) | on PEX | ||
3 | na | na | <3 | na | na | P (7.5) |
4 | na | na | 6 | na | na | P (3.5) |
5 | 40 | Miscarriage | P (2) | Miscarriage | ||
6 | na | Miscarriage | na | Miscarriage | ||
7 | 14 | Miscarriage | P (4.4) | Miscarriage | ||
8 | na | Miscarriage | na | Miscarriage | ||
9 | 20 | Miscarriage | P (<1.18) | Miscarriage | ||
10 | 129 | 97 | 70 | N | N | N |
11 | 40 | 39 | 45 | N | N | N |
12 | 90 | 84 | 80 | N | N | N |
13 | na | na | 73 | na | na | N |
14 | 64 | 96 | 68 | N | N | N |
15 | 90 | na | na | N | na | na |